Skip to main content
SpringerLink
Log in

New drugs for improving coronary vessel patency

  • Newsletter Article
  • Published:
Inpharma Weekly

Abstract

The latest results from a study of the tissue plasminogen activator monteplase may lead to ‘a new era in the thrombolytic treatment of acute MI [myocardial infarction]’ , according to Professor C Kawai from Japan. Monteplase was shown to produce earlier reperfusion, at a higher rate, than that achieved with alteplase in patients with MI. The results of the trial were presented at the 6th International Symposium on Cardiovascular Pharmacotherapy (ISCP) [ Sydney, Australia; February 1996 ], along with recent study data from 2 studies of GPIIb/IIIa receptor antagonists.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Authors
  1. Gill Higgins
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Higgins, G. New drugs for improving coronary vessel patency. Inpharma Wkly. 1031, 9–10 (1996). https://doi.org/10.2165/00128413-199610310-00018

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128413-199610310-00018

Keywords

Search

Navigation